Advertisement

Topics

BioMarin files BLA of phenylketonuria drug to FDA

04:11 EDT 3 Jul 2017 | SmartBrief

A biologics license application has been filed by BioMarin Pharmaceutical for pegvaliase, indicated to treat patients with ph -More

Original Article: BioMarin files BLA of phenylketonuria drug to FDA

NEXT ARTICLE

More From BioPortfolio on "BioMarin files BLA of phenylketonuria drug to FDA"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...